Katoh, Norito
Takita, Yasushi
Isaka, Yoshitaka
Nishikawa, Atsushi
Torisu-Itakura, Hitoe http://orcid.org/0000-0002-3200-2882
Saeki, Hidehisa
Clinical trials referenced in this document:
Documents that mention this clinical trial
Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials
https://doi.org/10.1007/s13555-022-00828-5
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials
https://doi.org/10.1007/s40257-021-00602-x
Documents that mention this clinical trial
Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials
https://doi.org/10.1007/s13555-022-00828-5
Baricitinib Rapidly Improves Skin Pain Resulting in Improved Quality of Life for Patients with Atopic Dermatitis: Analyses from BREEZE-AD1, 2, and 7
https://doi.org/10.1007/s13555-021-00577-x
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials
https://doi.org/10.1007/s40257-021-00602-x
Documents that mention this clinical trial
Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials
https://doi.org/10.1007/s13555-022-00828-5
Baricitinib Rapidly Improves Skin Pain Resulting in Improved Quality of Life for Patients with Atopic Dermatitis: Analyses from BREEZE-AD1, 2, and 7
https://doi.org/10.1007/s13555-021-00577-x
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials
https://doi.org/10.1007/s40257-021-00602-x
Documents that mention this clinical trial
Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials
https://doi.org/10.1007/s13555-022-00828-5
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials
https://doi.org/10.1007/s40257-021-00602-x
Documents that mention this clinical trial
Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials
https://doi.org/10.1007/s13555-022-00828-5
Baricitinib Rapidly Improves Skin Pain Resulting in Improved Quality of Life for Patients with Atopic Dermatitis: Analyses from BREEZE-AD1, 2, and 7
https://doi.org/10.1007/s13555-021-00577-x
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials
https://doi.org/10.1007/s40257-021-00602-x
Documents that mention this clinical trial
Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials
https://doi.org/10.1007/s13555-022-00828-5
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials
https://doi.org/10.1007/s40257-021-00602-x
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 4 August 2022
Accepted: 28 September 2022
First Online: 18 October 2022